The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
According to MarketsandMarkets™, the Biosimilars Market is projected to reach USD 70.79 billion by 2036 from USD 37.39 billion in 2026, at a CAGR of 6.6% during the forecast period.
Biocon Biologics Merger with Biocon: Biocon is sharpening its global biosimilars strategy with a renewed focus on consolidation, cost optimisation and long-term capex planning. In a conversation with ...
The Inflation Reduction Act (IRA) has reshaped how Medicare covers and reimburses prescription drugs. For the first time, the federal government established prices for ten drugs selected through the ...
Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, is thrilled to announce the signing of a landmark licensing agreement with ...
Biocon Biologics also announced it received FDA approval for the Yesfali PFS (the pre-filled syringe application), a vascular endothelial growth factor inhibitor used to treat several different types ...
CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated biopharmaceutical company based in Chicago and focused on the development and commercialization of generic ...
India has firmly established itself as the world's major producer of generic drugs. It is currently ranked third in ...
The MarketWatch News Department was not involved in the creation of this content. Company's third biosimilar expands access to proven targeted biologic therapy with patient-centric support services ...
Currently, the global biosimilars market includes monoclonal antibody (mAb) biosimilars, insulins, interferons, erythropoietins, filgrastim, somatropin and follicle-stimulating hormone. Of these, the ...
Formycon AG is betting big on high?value biosimilars for blockbuster biologics like Eylea and Stelara. Here’s how its focused pipeline, technology, and deals are reshaping the market. For all the hype ...
Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. Alvotech ( (ALVO)) has provided an update. Alvotech, the Nasdaq-listed biosimilars specialist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results